Trial
NCT05949632
A Study of INCB099280 in Combination With Axitinib in Adults With Advanced Solid Tumors
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Incyte Corporation
Collaborators
—
Condition
Advanced Solid Tumors
Intervention
INCB099280
Why stopped
This was a strategic business decision. There were no safety concerns contributing to this decision.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-06-04